Nuria Oliva Jorge PhD

TECHNIOspring Plus Postdoctoral Fellow

Nuria Oliva Jorge graduated from Institut Quimic de Sarria, Universitat Ramon Llull (Barcelona, Spain) with a Bachelor of Science in Organic Chemistry. She then received her PhD in Medical Engineering and Medical Physics (MEMP) at the Harvard-MIT Division of Health Sciences and Technology (HST); training under the guidance of Prof Elazer Edelman and Prof Natalie Artzi, Nuria focused on the development of a novel adhesive hydrogel and its use as a model platform to understand how disease microenvironment affects material performance and how to leverage those cues to attain tumor cell-selective delivery of chemotherapy in a local and sustained manner. She then spent one year at Brigham and Women's Hospital (Harvard Medical School) as a NIH Ruth L. Kirschstein post-doctoral fellow within the Organ Design and Engineering Training Program (ODET) at Brigham and Women’s Hospital (Harvard Medical School). Nuria then joined the Almquist Lab at Imperial College London in 2017, where she is developing novel DNA nanotechnology-based approach for modulating bone regeneration.



Imperial College London

Postdoctoral Researcher


Harvard Medical School

Postdoctoral Fellow


Massachusetts Institute of Technology

PhD Medical Engineering & Medical Physics


Instituto Químico de Sarrià

BS Organic Chemistry


Biologically Inspired, Cell-Selective Release of Aptamer-Trapped Growth Factors by Traction Forces

Stejskalová A, Oliva N, England FJ, Almquist BD. Advanced Materials, 31, 1806380 (2019).

Designing Hydrogels for On-Demand Therapy

Oliva N, Conde J, Wang K, Artzi N. Accounts of Chemical Research, 50, 660-679 (2017).

Local triple-combination therapy results in tumour regression and prevents recurrence in a colon cancer model

Conde J, Oliva N, Zhang Y, Artzi N. Nature Materials, 15, 1128-1138 (2016).

Local microRNA delivery targets Palladin and prevents metastatic breast cancer

Gilam A, Conde J, Weissglas-Volkov D, Oliva N, Friedman E, Artzi N, Shomron N. Nature Communications, 7, 12868 (2016).

Revisiting the ‘One Material Fits All’ Rule for Cancer Nanotherapy

Conde J, Oliva N, Artzi N. Trends in Biotechnology, 34, 618-626 (2016).

Self-assembled RNA-triple-helix hydrogel scaffold for microRNA modulation in the tumour microenvironment

Conde J, Oliva N, Atilano M, Song HS, Artzi N. Nature Materials, 15, 353-363 (2016).

Chapter 6: Injectable Hydrogels as Tissue Adhesives

Oliva N & Artzi N. Injectable Hydrogels for Regenerative Engineering, World Scientific, 239-273 (2016).

Personalizing biomaterials for precision nanomedicine considering the local tissue microenvironment

Oliva N, Unterman S, Zhang Y, Conde J, Song HS, Artzi N. Advanced Healthcare Materials, 4, 1584-1599 (2015).

Implantable hydrogel embedded dark-gold nanoswitch as a theranostic probe to sense and overcome cancer multidrug resistance

Conde J, Oliva N, Artzi N. Proceedings of the National Academy of Sciences, 112, E1278-E1287 (2015).

Regulation of dendrimer/dextran material performance by altered tissue microenvironment in inflammation and neoplasia

Oliva N, Carcole M, Beckerman M, Seliktar S, Hayward A, Stanley J, Parry NMA, Edelman ER, Artzi N. Science Translational Medicince, 272, 272ra11 (2015).

Hydrogel Doped with Nanoparticles for Local Sustained Release of siRNA in Breast Cancer

Segovia N, Pont M, Oliva N, Ramos V, Borrós S, Artzi N. Advanced Healthcare Materials, 4, 271-280 (2014).

Natural Tissue Microenvironmental Conditions Modulate Adhesive Material Performance

Oliva N, Shitreet S, Abraham E, Stanley B, Edelman ER, Artzi N. Langmuir, 28, 15402-15409 (2012).

In vivo and in vitro tracking of erosion in biodegradable materials using non-invasive fluorescence imaging

Artzi N, Oliva N, Puron C, Shitreet S, Artzi S, bon Ramos A, Groothuis A, Sahagian G, Edelman ER. Nature Materials, 10, 704-709 (2012).